What's in Aesculape CRO Belgium BV's pipeline?

Aesculape CRO Belgium BV has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Aesculape CRO Belgium BV's portfolio?

Top competitors by shared drug class: Ache Laboratorios Farmaceuticos S.A., AmDerma, Bausch Health Americas, Inc., Bayer, Fakultas Kedokteran Universitas Indonesia.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/aesculape-cro-belgium-bv.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Aesculape CRO Belgium BV — Portfolio Competitive Intelligence Brief

Aesculape CRO Belgium BV pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Miconazole Nitrate 2%	Miconazole Nitrate 2%	marketed	Imidazole antifungal	Lanosterol 14α-demethylase (CYP51)	Dermatology / Infectious Disease

Therapeutic area mix

Dermatology / Infectious Disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Ache Laboratorios Farmaceuticos S.A. · 1 shared drug class
AmDerma · 1 shared drug class
Bausch Health Americas, Inc. · 1 shared drug class
Bayer · 1 shared drug class
Fakultas Kedokteran Universitas Indonesia · 1 shared drug class
Galderma R&D · 1 shared drug class
Hayat Abad Medical Complex, Peshawar · 1 shared drug class
Jamaica Hospital Medical Center · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Aesculape CRO Belgium BV:

Cite this brief

Drug Landscape (2026). Aesculape CRO Belgium BV — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/aesculape-cro-belgium-bv. Accessed 2026-05-16.